These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9048756)

  • 1. 125I-galanin binding sites in Alzheimer's disease: increases in hippocampal subfields and a decrease in the caudate nucleus.
    Rodríguez-Puertas R; Nilsson S; Pascual J; Pazos A; Hökfelt T
    J Neurochem; 1997 Mar; 68(3):1106-13. PubMed ID: 9048756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of [125I]galanin binding sites despite loss of cholinergic neurones to the hippocampus in Alzheimer's disease.
    Ikeda M; Dewar D; McCulloch J
    Brain Res; 1991 Dec; 568(1-2):303-6. PubMed ID: 1726069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased densities of dopamine D1 receptors in the putamen and hippocampus in senile dementia of the Alzheimer type.
    Cortés R; Probst A; Palacios JM
    Brain Res; 1988 Dec; 475(1):164-7. PubMed ID: 2975188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis.
    Mufson EJ; Deecher DC; Basile M; Izenwasse S; Mash DC
    Neuropharmacology; 2000 Jun; 39(8):1404-12. PubMed ID: 10818256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin receptors in the post-mortem human brain. Regional distribution of 125I-galanin binding sites using the method of in vitro receptor autoradiography.
    Köhler C; Chan-Palay V
    Neurosci Lett; 1990 Dec; 120(2):179-82. PubMed ID: 1705678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
    Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I
    Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile.
    Nordberg A; Nyberg P; Adolfsson R; Winblad B
    J Neural Transm; 1987; 69(1-2):19-32. PubMed ID: 3585318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients.
    Lang W; Henke H
    Brain Res; 1983 May; 267(2):271-80. PubMed ID: 6871676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis.
    Pérez S; Basile M; Mash DC; Mufson EJ
    J Chem Neuroanat; 2002 Jul; 24(2):109-16. PubMed ID: 12191727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [125I]-Galanin binding in brain of wildtype, and galanin- and GalR1-knockout mice: strain and species differences in GalR1 density and distribution.
    Jungnickel SR; Gundlach AL
    Neuroscience; 2005; 131(2):407-21. PubMed ID: 15708483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [125I]-galanin binding sites in the human nodose ganglion.
    Sweerts BW; Jarrott B; Lawrence AJ
    Life Sci; 2000 Oct; 67(22):2685-90. PubMed ID: 11105984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system.
    Melander T; Köhler C; Nilsson S; Hökfelt T; Brodin E; Theodorsson E; Bartfai T
    J Chem Neuroanat; 1988; 1(4):213-33. PubMed ID: 2477035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective reduction of [125I]apamin binding sites in Alzheimer hippocampus: a quantitative autoradiographic study.
    Ikeda M; Dewar D; McCulloch J
    Brain Res; 1991 Dec; 567(1):51-6. PubMed ID: 1667746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and localization of galanin receptors in human entorhinal cortex.
    Deecher DC; Mash DC; Staley JK; Mufson EJ
    Regul Pept; 1998 Feb; 73(3):149-59. PubMed ID: 9556077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
    Chalmers DT; Dewar D; Graham DI; Brooks DN; McCulloch J
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1352-6. PubMed ID: 2154742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease.
    Waters SM; David TP
    J Gerontol A Biol Sci Med Sci; 1995 Sep; 50(5):B315-9. PubMed ID: 7545530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is senile dementia of the Alzheimer type associated with hippocampal plasticity?
    Represa A; Duyckaerts C; Tremblay E; Hauw JJ; Ben-Ari Y
    Brain Res; 1988 Aug; 457(2):355-9. PubMed ID: 2905920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic mapping of galanin receptors in the monkey brain.
    Köhler C; Hallman H; Melander T; Hökfelt T; Norheim E
    J Chem Neuroanat; 1989; 2(5):269-84. PubMed ID: 2478160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galanin receptor binding sites in the temporal and occipital cortex are minimally affected in Alzheimer's disease.
    Ikeda M; Dewar D; McCulloch J
    Neurosci Lett; 1995 Jun; 192(1):37-40. PubMed ID: 7675305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.